Cosmos Health (COSM) Operating Income (2010 - 2026)
Cosmos Health's (COSM) quarterly Operating Income came in at -$2.9 million in Q2 2026, down 10.6% on a YoY basis from -$3.3 million in Q2 2025, and down 33.95% quarter-over-quarter from -$2.2 million in Q1 2026.
Analysis
Cosmos Health (COSM) Operating Income (2010 - 2026) Analysis & Trends
Cosmos Health (COSM) has reported Operating Income for 17 consecutive years, with -$2.9 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Operating Income fell 10.6% year-over-year to -$2.9 million; the trailing twelve-month figure through Jun 2026 stood at -$18.3 million (down 24.85% YoY), and the FY2025 full-year result was -$16.7 million, down 7.45% from the prior year.
- Operating Income eased to -$2.9 million in Q2 2026 per COSM's latest filing, from -$2.2 million in the prior quarter.
- Across five years, Operating Income topped out at $242251.0 in Q1 2022 and bottomed at -$13.6 million in Q4 2023.
- Historically, Operating Income has averaged -$3.7 million across 5 years, with a median of -$2.5 million in 2023.
- The sharpest annual moves came in 2022 and 2023: Operating Income soared 113.99% in 2022, then tumbled 3364.71% in 2023.
- Over 5 years, Operating Income stood at -$7.3 million in 2022, then plunged by 86.17% to -$13.6 million in 2023, then soared by 34.0% to -$9.0 million in 2024, then decreased by 27.21% to -$11.4 million in 2025, then surged by 74.35% to -$2.9 million in 2026.
- According to Business Quant data, Operating Income over the past three periods registered -$2.9 million, -$2.2 million, and -$11.4 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.33 Bn | 38.68 Bn | 2.15 Bn | -231.00 Mn |
| 2 | Viatris | 19.05 Bn | 18.16 Bn | 1.46 Bn | 6.30 Mn |
| 3 | Dr Reddys Laboratories | 9.76 Bn | 9.58 Bn | 396.53 Mn | 39.97 Mn |
| 4 | Amneal Pharmaceuticals | 5.38 Bn | 5.25 Bn | 334.51 Mn | 129.77 Mn |
| 5 | Bausch Health Companies | 2.27 Bn | 436.38 Mn | 2.10 Bn | 740.00 Mn |
| 6 | Alvotech | 1.51 Bn | 1.37 Bn | 2.56 Mn | -73.42 Mn |
| 7 | Ani Pharmaceuticals | 1.51 Bn | 1.15 Bn | 165.89 Mn | 40.46 Mn |
| 8 | Amphastar Pharmaceuticals | 1.03 Bn | 737.26 Mn | 93.47 Mn | 39.73 Mn |
| 9 | Fennec Pharmaceuticals | 393.12 Mn | 351.87 Mn | 17.15 Mn | 1.74 Mn |
| 10 | Cosmos Health | 15.08 Mn | 12.63 Mn | 1.51 Mn | -2.93 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -2.93 Mn |
| Mar 31, 2026 | -2.18 Mn |
| Dec 31, 2025 | -11.41 Mn |
| Sep 30, 2025 | -1.82 Mn |
| Jun 30, 2025 | -2.65 Mn |
| Mar 31, 2025 | -833,145.00 |
| Dec 31, 2024 | -8.97 Mn |
| Sep 30, 2024 | -2.24 Mn |
| Jun 30, 2024 | -2.50 Mn |
| Mar 31, 2024 | -1.84 Mn |
| Dec 31, 2023 | -13.59 Mn |
| Sep 30, 2023 | -3.02 Mn |
| Jun 30, 2023 | -2.58 Mn |
| Mar 31, 2023 | -2.65 Mn |
| Dec 31, 2022 | -7.30 Mn |
| Sep 30, 2022 | -344,112.00 |
| Jun 30, 2022 | -74,363.00 |
| Mar 31, 2022 | 242,251.00 |
| Dec 31, 2021 | -511,284.00 |
| Sep 30, 2021 | -914,551.00 |